Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details) - Schedule of stock option activity under our equity plans

v3.22.1
Stock-Based Compensation (Details) - Schedule of stock option activity under our equity plans - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]    
Number of Shares, Beginning 10,589,010  
Number of Shares, Granted 688,240  
Number of shares, exercised (50,000)  
Number of Shares, Exercisable 4,357,385  
Number of Shares, Ending 11,227,250 10,589,010
Number of Shares, Vested and expected to vest 11,227,250  
Weighted Average Exercise Price, Beginning (in Dollars per share) $ 14.85  
Weighted Average Exercise Price, Granted (in Dollars per share) 3.96  
Weighted Average Exercise Price, Exercised (in Dollars per share) 3.28  
Weighted Average Exercise Price, Ending (in Dollars per share) 14.24 $ 14.85
Weighted Average Exercise Price, Exercisable (in Dollars per share) 4.78  
Weighted Average Exercise Price, Vested and expected to vest (in Dollars per share) $ 14.24  
Weighted Average Remaining Contractual Term (Years) 7 years 3 months 25 days 7 years 4 months 20 days
Weighted Average Remaining Contractual Term (Years), Exercisable 4 years 11 months 15 days  
Weighted Average Remaining Contractual Term (Years), Vested and expected to vest 7 years 3 months 25 days  
Aggregate Intrinsic Value, Beginning (in Dollars) $ 22,473,835  
Aggregate Intrinsic Value, Exercised (in Dollars) 81,300  
Aggregate Intrinsic Value, Ending (in Dollars) 11,642,645 $ 22,473,835
Aggregate Intrinsic Value, Exercisable (in Dollars) 10,334,662  
Aggregate Intrinsic Value, Vested and expected to vest (in Dollars) $ 11,642,645